RNA Ç¥Àû ÀúºÐÀÚ Drug Discovery ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ - ÀûÀÀÁõº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø, ºÎ¹® ¿¹Ãø(2025-2030³â)
RNA Targeting Small Molecule Drug Discovery Market Size, Share & Trends Analysis Report By Indication (Cancer, Infectious Diseases, Metabolic Diseases, Neurological Diseases), By End-use, By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1701350
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 120 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,311,000
Unprintable PDF & Excel (Single User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» 1Àθ¸ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,708,000
Printable PDF & Excel (5-User License) help
º¸°í¼­ PDF ¹× ¿¢¼¿À» µ¿ÀÏ ±â¾÷ ³» µ¿ÀÏ ºÎ¼­¿¡¼­ ÃÖ´ë 5¸í±îÁö »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, Àμâ´Â °¡´ÉÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,502,000
Printable PDF & Excel (Enterprise License) help
º¸°í¼­ ±¸¸Å ±â¾÷ ¹× ±× ÀÚȸ»ç, °ü°è»ç°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀ̸ç, PDF ¹× ¿¢¼¿ ÅØ½ºÆ® µîÀÇ º¹»ç ¹× ºÙ¿©³Ö±â, ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

RNA Ç¥Àû ÀúºÐÀÚ Drug Discovery ½ÃÀåÀÇ ¼ºÀå ¹× µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°èÀÇ RNA Ç¥Àû ÀúºÐÀÚ Drug Discovery ½ÃÀå ±Ô¸ð´Â 2025-2030³â 21.9%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ Àü¸ÁÀ̸ç, 2030³â±îÁö 54¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù.

RNA Ç¥Àû ÀúºÐÀÚ Drug Discovery »ê¾÷Àº ´Ù¾çÇÑ Áúº´¿¡ ´ëÇÑ Ç¥ÀûÈ­µÇ°í È¿°úÀûÀÎ Ä¡·áÁ¦¸¦ °³¹ßÇÒ ¼ö Àֱ⠶§¹®¿¡ ±Þ¼ºÀåÀ» °è¼ÓÇϰí ÀÖ½À´Ï´Ù.

¾Ï, À¯Àü¼º Áúȯ, ¹ÙÀÌ·¯½º °¨¿° µîÀÇ Áúº´ À¯º´·ü Áõ°¡°¡ RNA Ç¥Àû ÀúºÐÀÚ ¾à¹° ¼ö¿ä¸¦ ºÎÃß±â°í ÀÖ½À´Ï´Ù. RNA Ç¥Àû ÀúºÐÀÚ Drug Discovery »ê¾÷Àº CRISPR-Cas9 ¹× RNA °£¼·°ú °°Àº ÃÖ÷´Ü ±â¼úÀÇ µµÀÔ¿¡ ÀÇÇØ ±ØÀûÀ¸·Î ¼ºÀåÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú¿¡ ÀÇÇØ Áúº´ÀÇ ¹ßº´¿¡ °ü¿©ÇÏ´Â RNA Ç¥ÀûÀÇ µ¿Á¤ÀÌ °¡´ÉÇØÁ® RNA¸¦ Ç¥ÀûÀ¸·Î ÇÏ´Â ¿ÏÀüÈ÷ »õ·Î¿î ÀúºÐÀÚ ÀǾàǰÀÌ ¸¸µé¾îÁö°í ÀÖ½À´Ï´Ù.

ÇâÈÄ ¼ö³â°£, Drug Discovery¸¦ À§ÇÑ RNA Ç¥Àû ÀúºÐÀÚ ½ÃÀåÀº Á¦¾àȸ»ç³ª ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷¿¡ ÀÇÇÑ ¿¬±¸°³¹ß Ȱµ¿¿¡ ´ëÇÑ ÁöÃâ Áõ°¡¿¡ °ßÀεǾî, ´ëÆøÀûÀÎ È®´ë°¡ ¿¹»óµË´Ï´Ù. Çõ½ÅÀûÀÎ RNA Ç¥Àû ÀúºÐÀÚ¸¦ âÁ¦ÇÏ´Â °úÁ¤¿¡´Â ½Ã°£°ú ºñ¿ëÀÌ µéÁö¸¸ ÁýÁßÀûÀ̰í È¿À²ÀûÀÎ Ä¡·á¶ó´Â ÀáÀçÀû º¸»óÀ» ¹ÞÀ» ¼ö Àֱ⠶§¹®¿¡ ÅõÀÚÇÒ ¸¸ÇÕ´Ï´Ù.

¿¹¸¦ µé¾î, 2020³â¿¡ ¸ðµ¥³ª°¡ ¹öÅØ½º ÆÄ¸Ó½´Æ¼Ä®½º¿Í °øµ¿À¸·Î ½Ç½ÃÇÑ ³¶Æ÷¼º ¼¶À¯Áõ Ä¡·á¿ë RNA Ç¥Àû ÀúºÐÀÚ ÀǾàǰÀÇ °³¹ßÀº ÀÌ ºÐ¾ß¿¡ ´ëÇÑ Áß¿äÇÑ ÅõÀÚÀÔ´Ï´Ù. ¸ð´õ³ª´Â ÀÚ»çÀÇ mRNA ±â¼ú Ç÷§ÆûÀ» »ç¿ëÇØ ½Å±Ô RNA Ç¥ÀûÀ» µ¿Á¤Çϰí, ¹öÅØ½º´Â ÀúºÐÀÚ ½Å¾àÀÇ Àü¹® Áö½ÄÀ» ÀÀ¿ëÇØ Ç¥Àû¿¡ ´ëÇÑ Ä¡·á¹ýÀ» °³¹ßÇÕ´Ï´Ù. ÀÌ Á¦ÈÞ´Â, Áúȯ Ä¡·á¿¡ Çõ¸íÀ» °¡Á®¿Ã °¡´É¼ºÀ» ³»Æ÷ÇÑ RNA Ç¥Àû ÀúºÐÀÚ Drug Discovery¿¡ ´ëÇÑ °ü½É°ú ÅõÀÚÀÇ °íÁ¶¸¦ ¹Ý¿µÇϰí ÀÖ½À´Ï´Ù.

RNA Ç¥Àû ÀúºÐÀÚ Drug Discovery ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý ¹× ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå RNA Ç¥Àû ÀúºÐÀÚ Drug Discovery ½ÃÀåÀÇ º¯¼ö, µ¿Çâ ¹× ¹üÀ§

Á¦4Àå RNA Ç¥Àû ÀúºÐÀÚ Drug Discovery ½ÃÀå : ÀûÀÀÁõº° ºñÁî´Ï½º ºÐ¼®

Á¦5Àå RNA Ç¥Àû ÀúºÐÀÚ Drug Discovery ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ºñÁî´Ï½º ºÐ¼®

Á¦6Àå RNA Ç¥Àû ÀúºÐÀÚ Drug Discovery ½ÃÀå : Áö¿ªº° ÃßÁ¤ ¹× µ¿Ç⠺м®

Á¦7Àå °æÀï ±¸µµ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

RNA Targeting Small Molecule Drug Discovery Market Growth & Trends:

The global RNA targeting small molecule drug discovery market size is estimated to reach USD 5.42 billion by 2030, registering a CAGR of 21.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. RNA-targeting small molecule drug discovery industry continues to undergo rapid growth due to its potential to develop targeted and effective therapeutics for various diseases.

The increasing prevalence of diseases such as cancer, genetic disorders, and viral infections has fueled the demand for RNA-targeting small-molecule drugs. The RNA-targeting small molecule drug discovery industry has grown dramatically as a result of the introduction of cutting-edge technologies like CRISPR-Cas9 and RNA interference. These technologies have made it possible to identify RNA targets that are implicated in the pathogenesis of diseases, which has resulted in the creation of brand-new small-molecule medications that target RNA.

In the upcoming years, the market for RNA targeting small molecules for drug discovery is anticipated to experience significant expansion, driven by the rising expenditure in R&D activities by pharmaceutical and biotechnology businesses. The process of creating innovative, RNA-targeting small molecules is time-consuming and costly, but the potential rewards of focused, efficient treatments make it a worthy investment.

For instance, in 2020 Moderna's recent collaboration with Vertex Pharmaceuticals to develop RNA-targeted small molecule drugs for the treatment of cystic fibrosis is a significant investment in this field. Moderna will use its mRNA technology platform to identify novel RNA targets, while Vertex will apply its expertise in small molecule drug discovery to develop therapies for the targets. This collaboration reflects the growing interest and investment in RNA-targeting small molecule drug discovery, which has the potential to revolutionize disease treatment.

RNA Targeting Small Molecule Drug Discovery Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. RNA Targeting Small Molecule Drug Discovery Market Variables, Trends, & Scope

Chapter 4. RNA Targeting Small Molecule Drug Discovery Market: Indication Business Analysis

Chapter 5. RNA Targeting Small Molecule Drug Discovery Market: End Use Business Analysis

Chapter 6. RNA Targeting Small Molecule Drug Discovery Market: Regional Estimates & Trend Analysis

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â